News

Genasys Inc. (GNSS) Q4 2025 Earnings Call Transcript

1 Mins read

Operator

Good day, everyone, and welcome to Genasys’ Fourth Quarter and Fiscal Full Year-End Results Call. At this time, I would like to hand the call over to Mr. Clay Liolios. Please go ahead, sir.

Clay Liolios

Good afternoon, everyone. Thank you for participating in today’s conference call to discuss Genasys’ fiscal fourth quarter and full year results ended September 30, 2025. My name is Clay Liolios and I’m with the Gateway Group, the company’s third-party investor relations firm. Joining us on today’s call are Genasys Chief Executive Officer, Richard Danforth; and Interim Chief Financial Officer, Cassandra Monteon.

Before we begin, let me remind everyone of the company’s safe harbor disclaimer. Certain portions of our comments today will concern future expectations, plans and prospects of the company that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements containing verbs such as aims, anticipates, estimates, expects, believes, intends, plans, predicts, will, may, continue, projects or targets and negatives of these words and similar words or expressions.

Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could affect our actual results include, among others, those that are discussed under the heading Risk Factors in our most recently filed reports with the SEC, including our annual report on Form 10-K, our quarterly

Read the full article here

Related posts
News

NowVertical Group Inc. (NOW:CA) Discusses Business Model, AI-Driven Solutions, Key Metrics and Growth Strategy Transcript

1 Mins read
Follow NowVertical Group Inc. (NOW:CA) Discusses Business Model, AI-Driven Solutions, Key Metrics and Growth Strategy December 10, 2025 2:00 PM EST Company…
News

Syndax Pharmaceuticals, Inc. (SNDX) Presents at The 67th American Society of Hematology (ASH) Annual Meeting Transcript

1 Mins read
Follow Play Earnings CallPlay Earnings Call Syndax Pharmaceuticals, Inc. (SNDX) The 67th American Society of Hematology (ASH) Annual Meeting December 8, 2025…
News

Incyte Corporation (INCY) Discusses mutCALR Data and Therapeutic Advances in Myeloproliferative Neoplasms at ASH Transcript

1 Mins read
Conference Call Participants Claire HarrisonJohn MascarenhasBethan PsailaBrian Abrahams – RBC Capital Markets, Research DivisionErik Lavington – Mizuho Securities USA LLC, Research DivisionMichael…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *